금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Stock futures slip as U.S. and Canada appear headed for trade war
U.S. stock-index futures dipped on Sunday, as it appeared the U.S. was on the verge of an all-out tr...
An economic D-Day is coming for Iran
Countries that calculate appeasement of the regime to be a safer choice should reconsider...
Stock Futures Could Reflect Unease With Trump’s Tariff Fight With Canada
The U.S. imposed a 50% tariff on about $20 billion worth of Canadian imports after talks between the...
Macy's (M) Gains But Lags Market: What You Should Know
In the closing of the recent trading day, Macy's (M) stood at $26.21, denoting a +1% move from the preceding trading day.
Home Depot (HD) Surpasses Market Returns: Some Facts Worth Knowing
Home Depot (HD) concluded the recent trading session at $348.24, signifying a +2.42% move from its prior day's close.
Why Gold.com (GOLD) Outpaced the Stock Market Today
The latest trading day saw Gold.com (GOLD) settling at $42.9, representing a +1.83% change from its previous close.
Charlie’s Holdings names Henry Sicignano as CEO ahead of age-gated vape launch
Gold gains as lower oil prices, lackluster U.S. jobs data ease inflation fears
Stride GAAP EPS of $7.14 beats by $0.07, revenue of $2.52B beats by $10M
Pfizer Covid Pill Revenue Plunges 95%. The Stock Is Rising Anyway.
Pfizer beats earnings forecasts for the second quarter, while BioNTech’s results miss expectations due to weak Covid vaccine demand.
Par Pacific earnings surge on strong refining margins amid turnaround
Tyra Biosciences GAAP EPS of -$0.69 misses by $0.04
Stocks face their weakest seasonal stretch. Why extreme investor pessimism could limit any selling.
U.S. stocks are entering what has historically been the weakest stretch of the year, but unusually bearish investor sentiment could help limit any pullback, according to Ned Davis Research.
Novo Nordisk Raises Earnings Guidance. The Stock Sinks.
The Danish drugmaker continues to rely on the success of semaglutide, branded as Wegovy for weight loss and Ozempic for diabetes.
Transcat Non-GAAP EPS of $0.51 beats by $0.13, revenue of $92.95M beats by $6.4M